Further investigation of clinical samples using qRT-PCR analysis of mRNA levels in 223 ER-positive primary breast cancers from patients who had recurrent metastatic disease and were treated with tamoxifen as a first-line therapy, revealed a high PSAP expression level for 182 out of 223 patients. Here, PSAP is linked to breast carcinoma.